BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 35834904)

  • 1. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
    Song J; Wang SH; Song CH; Zhang WX; Zhu JX; Tian XY; Fu XJ; Xu Y; Jin CY; Zhang SY
    Eur J Med Chem; 2022 Oct; 240():114583. PubMed ID: 35834904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers.
    Yuan XY; Song CH; Liu XJ; Wang X; Jia MQ; Wang W; Liu WB; Fu XJ; Jin CY; Song J; Zhang SY
    Eur J Med Chem; 2023 Apr; 252():115281. PubMed ID: 36940611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
    Song J; Guan YF; Liu WB; Song CH; Tian XY; Zhu T; Fu XJ; Qi YQ; Zhang SY
    Eur J Med Chem; 2022 Aug; 238():114467. PubMed ID: 35605363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities.
    Tian XY; Zhang WX; Chen XY; Jia MQ; Zhang SY; Chen YF; Yuan S; Song J; Li J
    Eur J Med Chem; 2024 Feb; 265():116079. PubMed ID: 38150962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway.
    Song J; Gao QL; Wu BW; Zhu T; Cui XX; Jin CJ; Wang SY; Wang SH; Fu DJ; Liu HM; Zhang SY; Zhang YB; Li YC
    Eur J Med Chem; 2020 Oct; 203():112618. PubMed ID: 32682200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
    Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
    Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
    Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
    Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities.
    Song J; Wang SY; Wang X; Jia MQ; Tian XY; Fu XJ; Jin CY; Zhang SY
    Bioorg Chem; 2023 Aug; 137():106580. PubMed ID: 37149948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.
    Li YR; Liu FF; Liu WB; Zhang YF; Tian XY; Fu XJ; Xu Y; Song J; Zhang SY
    Biochem Pharmacol; 2022 Jul; 201():115070. PubMed ID: 35526597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation.
    Hagras M; El Deeb MA; Elzahabi HSA; Elkaeed EB; Mehany ABM; Eissa IH
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):640-658. PubMed ID: 33588683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
    Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T
    Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel 2-(trifluoromethyl)quinolin-4-amine derivatives as potent antitumor agents with microtubule polymerization inhibitory activity.
    Liu K; Mo M; Yu G; Yu J; Song SM; Cheng S; Li HM; Meng XL; Zeng XP; Xu GC; Luo H; Xu BX
    Bioorg Chem; 2023 Oct; 139():106727. PubMed ID: 37451147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors.
    Liu R; Zhang S; Huang M; Guo Z; Li L; Li M; Wu L; Guan Q; Zhang W
    Bioorg Chem; 2021 Oct; 115():105220. PubMed ID: 34352709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site.
    Yang Y; Cao Y; Yu J; Yu X; Guo Y; Wang F; Ren Q; Li C
    Eur J Med Chem; 2024 Mar; 267():116177. PubMed ID: 38280356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors.
    Liang T; Zhou X; Lu L; Dong H; Zhang Y; Xu Y; Qi J; Zhang Y; Wang J
    Bioorg Chem; 2021 May; 110():104793. PubMed ID: 33770673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based approaches for the design of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d][1,2,3]triazoles as tubulin polymerization inhibitors.
    Huang M; Han H; Liu H; Liu R; Li J; Li M; Guan Q; Zhang W; Wang D
    Eur J Med Chem; 2024 Apr; 269():116309. PubMed ID: 38471357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors.
    Tan Y; Hu H; Zhu W; Wang T; Gao T; Wang H; Chen J; Xu J; Xu S; Zhu H
    Eur J Med Chem; 2023 Dec; 262():115881. PubMed ID: 37883897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.